Date: 2011-05-13
Type of information: Fundraising
Company: Advicenne Pharma (France)
Investors: Innobio (France) - IXO Private Equity (France) - Private investors
Amount: €5.1 million
Funding type: venture capital
Planned used: Advicenne Pharma is focused on development and marketing of paediatric products adressed to neurological diseases and nephrological disorders. These funds will be used for the clinical development and the registration of its two first products.
Others: Innobio has invested €3 million in Advicenne Pharma. The company has also secured €1.25 million with Ixo Private Equity, a french independant regional fund. Private investors have completed this roundtable.
Therapeutic area: CNS diseases - Renal diseases
